img

Global Injectable Drug Delivery Formulation Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Injectable Drug Delivery Formulation Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Injectable Drug Delivery Formulation report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Injectable Drug Delivery Formulation market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Autoimmune Diseases and Hormonal Disorders are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Injectable Drug Delivery Formulation industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Injectable Drug Delivery Formulation key manufacturers include Becton, Dickinson and Company (US), Baxter International Inc. (US), Gerresheimer AG (Germany), Pfizer, Inc. (US), Schott AG (Germany), Sandoz (Germany), Teva Pharmaceutical Industries Ltd. (Israel) and Eli Lilly and Company (US), etc. Becton, Dickinson and Company (US), Baxter International Inc. (US), Gerresheimer AG (Germany) are top 3 players and held % sales share in total in 2022.
Injectable Drug Delivery Formulation can be divided into Conventional Drug Delivery Formulations, Novel Drug Delivery Formulations and Long-acting Formulations,, etc. Conventional Drug Delivery Formulations is the mainstream product in the market, accounting for % sales share globally in 2022.
Injectable Drug Delivery Formulation is widely used in various fields, such as Autoimmune Diseases, Hormonal Disorders, Oncology and Orphan Diseases, etc. Autoimmune Diseases provides greatest supports to the Injectable Drug Delivery Formulation industry development. In 2022, global % sales of Injectable Drug Delivery Formulation went into Autoimmune Diseases filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Injectable Drug Delivery Formulation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Becton, Dickinson and Company (US)
Baxter International Inc. (US)
Gerresheimer AG (Germany)
Pfizer, Inc. (US)
Schott AG (Germany)
Sandoz (Germany)
Teva Pharmaceutical Industries Ltd. (Israel)
Eli Lilly and Company (US)
Segment by Type
Conventional Drug Delivery Formulations
Novel Drug Delivery Formulations
Long-acting Formulations

Segment by Application


Autoimmune Diseases
Hormonal Disorders
Oncology
Orphan Diseases
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Injectable Drug Delivery Formulation market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Injectable Drug Delivery Formulation, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Injectable Drug Delivery Formulation industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Injectable Drug Delivery Formulation in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Injectable Drug Delivery Formulation introduction, etc. Injectable Drug Delivery Formulation Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Injectable Drug Delivery Formulation market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Injectable Drug Delivery Formulation Market Overview
1.1 Injectable Drug Delivery Formulation Product Overview
1.2 Injectable Drug Delivery Formulation Market Segment by Type
1.2.1 Conventional Drug Delivery Formulations
1.2.2 Novel Drug Delivery Formulations
1.2.3 Long-acting Formulations
1.3 Global Injectable Drug Delivery Formulation Market Size by Type
1.3.1 Global Injectable Drug Delivery Formulation Market Size Overview by Type (2018-2034)
1.3.2 Global Injectable Drug Delivery Formulation Historic Market Size Review by Type (2018-2024)
1.3.3 Global Injectable Drug Delivery Formulation Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Injectable Drug Delivery Formulation Sales Breakdown by Type (2018-2024)
1.4.2 Europe Injectable Drug Delivery Formulation Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Injectable Drug Delivery Formulation Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Injectable Drug Delivery Formulation Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Injectable Drug Delivery Formulation Sales Breakdown by Type (2018-2024)
2 Global Injectable Drug Delivery Formulation Market Competition by Company
2.1 Global Top Players by Injectable Drug Delivery Formulation Sales (2018-2024)
2.2 Global Top Players by Injectable Drug Delivery Formulation Revenue (2018-2024)
2.3 Global Top Players by Injectable Drug Delivery Formulation Price (2018-2024)
2.4 Global Top Manufacturers Injectable Drug Delivery Formulation Manufacturing Base Distribution, Sales Area, Product Type
2.5 Injectable Drug Delivery Formulation Market Competitive Situation and Trends
2.5.1 Injectable Drug Delivery Formulation Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Injectable Drug Delivery Formulation Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Injectable Drug Delivery Formulation as of 2022)
2.7 Date of Key Manufacturers Enter into Injectable Drug Delivery Formulation Market
2.8 Key Manufacturers Injectable Drug Delivery Formulation Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Injectable Drug Delivery Formulation Status and Outlook by Region
3.1 Global Injectable Drug Delivery Formulation Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Injectable Drug Delivery Formulation Historic Market Size by Region
3.2.1 Global Injectable Drug Delivery Formulation Sales in Volume by Region (2018-2024)
3.2.2 Global Injectable Drug Delivery Formulation Sales in Value by Region (2018-2024)
3.2.3 Global Injectable Drug Delivery Formulation Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Injectable Drug Delivery Formulation Forecasted Market Size by Region
3.3.1 Global Injectable Drug Delivery Formulation Sales in Volume by Region (2024-2034)
3.3.2 Global Injectable Drug Delivery Formulation Sales in Value by Region (2024-2034)
3.3.3 Global Injectable Drug Delivery Formulation Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Injectable Drug Delivery Formulation by Application
4.1 Injectable Drug Delivery Formulation Market Segment by Application
4.1.1 Autoimmune Diseases
4.1.2 Hormonal Disorders
4.1.3 Oncology
4.1.4 Orphan Diseases
4.1.5 Others
4.2 Global Injectable Drug Delivery Formulation Market Size by Application
4.2.1 Global Injectable Drug Delivery Formulation Market Size Overview by Application (2018-2034)
4.2.2 Global Injectable Drug Delivery Formulation Historic Market Size Review by Application (2018-2024)
4.2.3 Global Injectable Drug Delivery Formulation Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Injectable Drug Delivery Formulation Sales Breakdown by Application (2018-2024)
4.3.2 Europe Injectable Drug Delivery Formulation Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Injectable Drug Delivery Formulation Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Injectable Drug Delivery Formulation Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Injectable Drug Delivery Formulation Sales Breakdown by Application (2018-2024)
5 North America Injectable Drug Delivery Formulation by Country
5.1 North America Injectable Drug Delivery Formulation Historic Market Size by Country
5.1.1 North America Injectable Drug Delivery Formulation Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Injectable Drug Delivery Formulation Sales in Volume by Country (2018-2024)
5.1.3 North America Injectable Drug Delivery Formulation Sales in Value by Country (2018-2024)
5.2 North America Injectable Drug Delivery Formulation Forecasted Market Size by Country
5.2.1 North America Injectable Drug Delivery Formulation Sales in Volume by Country (2024-2034)
5.2.2 North America Injectable Drug Delivery Formulation Sales in Value by Country (2024-2034)
6 Europe Injectable Drug Delivery Formulation by Country
6.1 Europe Injectable Drug Delivery Formulation Historic Market Size by Country
6.1.1 Europe Injectable Drug Delivery Formulation Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Injectable Drug Delivery Formulation Sales in Volume by Country (2018-2024)
6.1.3 Europe Injectable Drug Delivery Formulation Sales in Value by Country (2018-2024)
6.2 Europe Injectable Drug Delivery Formulation Forecasted Market Size by Country
6.2.1 Europe Injectable Drug Delivery Formulation Sales in Volume by Country (2024-2034)
6.2.2 Europe Injectable Drug Delivery Formulation Sales in Value by Country (2024-2034)
7 Asia-Pacific Injectable Drug Delivery Formulation by Region
7.1 Asia-Pacific Injectable Drug Delivery Formulation Historic Market Size by Region
7.1.1 Asia-Pacific Injectable Drug Delivery Formulation Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Injectable Drug Delivery Formulation Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Injectable Drug Delivery Formulation Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Injectable Drug Delivery Formulation Forecasted Market Size by Region
7.2.1 Asia-Pacific Injectable Drug Delivery Formulation Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Injectable Drug Delivery Formulation Sales in Value by Region (2024-2034)
8 Latin America Injectable Drug Delivery Formulation by Country
8.1 Latin America Injectable Drug Delivery Formulation Historic Market Size by Country
8.1.1 Latin America Injectable Drug Delivery Formulation Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Injectable Drug Delivery Formulation Sales in Volume by Country (2018-2024)
8.1.3 Latin America Injectable Drug Delivery Formulation Sales in Value by Country (2018-2024)
8.2 Latin America Injectable Drug Delivery Formulation Forecasted Market Size by Country
8.2.1 Latin America Injectable Drug Delivery Formulation Sales in Volume by Country (2024-2034)
8.2.2 Latin America Injectable Drug Delivery Formulation Sales in Value by Country (2024-2034)
9 Middle East and Africa Injectable Drug Delivery Formulation by Country
9.1 Middle East and Africa Injectable Drug Delivery Formulation Historic Market Size by Country
9.1.1 Middle East and Africa Injectable Drug Delivery Formulation Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Injectable Drug Delivery Formulation Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Injectable Drug Delivery Formulation Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Injectable Drug Delivery Formulation Forecasted Market Size by Country
9.2.1 Middle East and Africa Injectable Drug Delivery Formulation Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Injectable Drug Delivery Formulation Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Becton, Dickinson and Company (US)
10.1.1 Becton, Dickinson and Company (US) Company Information
10.1.2 Becton, Dickinson and Company (US) Introduction and Business Overview
10.1.3 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Products Offered
10.1.5 Becton, Dickinson and Company (US) Recent Development
10.2 Baxter International Inc. (US)
10.2.1 Baxter International Inc. (US) Company Information
10.2.2 Baxter International Inc. (US) Introduction and Business Overview
10.2.3 Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Baxter International Inc. (US) Injectable Drug Delivery Formulation Products Offered
10.2.5 Baxter International Inc. (US) Recent Development
10.3 Gerresheimer AG (Germany)
10.3.1 Gerresheimer AG (Germany) Company Information
10.3.2 Gerresheimer AG (Germany) Introduction and Business Overview
10.3.3 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Products Offered
10.3.5 Gerresheimer AG (Germany) Recent Development
10.4 Pfizer, Inc. (US)
10.4.1 Pfizer, Inc. (US) Company Information
10.4.2 Pfizer, Inc. (US) Introduction and Business Overview
10.4.3 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Products Offered
10.4.5 Pfizer, Inc. (US) Recent Development
10.5 Schott AG (Germany)
10.5.1 Schott AG (Germany) Company Information
10.5.2 Schott AG (Germany) Introduction and Business Overview
10.5.3 Schott AG (Germany) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Schott AG (Germany) Injectable Drug Delivery Formulation Products Offered
10.5.5 Schott AG (Germany) Recent Development
10.6 Sandoz (Germany)
10.6.1 Sandoz (Germany) Company Information
10.6.2 Sandoz (Germany) Introduction and Business Overview
10.6.3 Sandoz (Germany) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Sandoz (Germany) Injectable Drug Delivery Formulation Products Offered
10.6.5 Sandoz (Germany) Recent Development
10.7 Teva Pharmaceutical Industries Ltd. (Israel)
10.7.1 Teva Pharmaceutical Industries Ltd. (Israel) Company Information
10.7.2 Teva Pharmaceutical Industries Ltd. (Israel) Introduction and Business Overview
10.7.3 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Products Offered
10.7.5 Teva Pharmaceutical Industries Ltd. (Israel) Recent Development
10.8 Eli Lilly and Company (US)
10.8.1 Eli Lilly and Company (US) Company Information
10.8.2 Eli Lilly and Company (US) Introduction and Business Overview
10.8.3 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Products Offered
10.8.5 Eli Lilly and Company (US) Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Injectable Drug Delivery Formulation Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Injectable Drug Delivery Formulation Industrial Chain Analysis
11.4 Injectable Drug Delivery Formulation Market Dynamics
11.4.1 Injectable Drug Delivery Formulation Industry Trends
11.4.2 Injectable Drug Delivery Formulation Market Drivers
11.4.3 Injectable Drug Delivery Formulation Market Challenges
11.4.4 Injectable Drug Delivery Formulation Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Injectable Drug Delivery Formulation Distributors
12.3 Injectable Drug Delivery Formulation Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Conventional Drug Delivery Formulations
Table 2. Major Company of Novel Drug Delivery Formulations
Table 3. Major Company of Long-acting Formulations
Table 4. Global Injectable Drug Delivery Formulation Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Injectable Drug Delivery Formulation Sales by Type (2018-2024) & (K Pcs)
Table 6. Global Injectable Drug Delivery Formulation Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Injectable Drug Delivery Formulation Sales by Type (2018-2024) & (US& Million)
Table 8. Global Injectable Drug Delivery Formulation Market Share in Value by Type (2018-2024)
Table 9. Global Injectable Drug Delivery Formulation Price by Type (2018-2024) & (USD/Pcs)
Table 10. Global Injectable Drug Delivery Formulation Sales by Type (2024-2034) & (K Pcs)
Table 11. Global Injectable Drug Delivery Formulation Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Injectable Drug Delivery Formulation Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Injectable Drug Delivery Formulation Sales Market Share in Value by Type (2024-2034)
Table 14. Global Injectable Drug Delivery Formulation Price by Type (2024-2034) & (USD/Pcs)
Table 15. North America Injectable Drug Delivery Formulation Sales by Type (2018-2024) & (K Pcs)
Table 16. North America Injectable Drug Delivery Formulation Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Injectable Drug Delivery Formulation Sales (K Pcs) by Type (2018-2024)
Table 18. Europe Injectable Drug Delivery Formulation Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Injectable Drug Delivery Formulation Sales (K Pcs) by Type (2018-2024)
Table 20. Asia-Pacific Injectable Drug Delivery Formulation Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Injectable Drug Delivery Formulation Sales (K Pcs) by Type (2018-2024)
Table 22. Latin America Injectable Drug Delivery Formulation Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Injectable Drug Delivery Formulation Sales (K Pcs) by Type (2018-2024)
Table 24. Middle East and Africa Injectable Drug Delivery Formulation Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Injectable Drug Delivery Formulation Sales by Company (2018-2024) & (K Pcs)
Table 26. Global Injectable Drug Delivery Formulation Sales Share by Company (2018-2024)
Table 27. Global Injectable Drug Delivery Formulation Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Injectable Drug Delivery Formulation Revenue Share by Company (2018-2024)
Table 29. Global Market Injectable Drug Delivery Formulation Price by Company (2018-2024) & (USD/Pcs)
Table 30. Global Injectable Drug Delivery Formulation Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Injectable Drug Delivery Formulation Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Injectable Drug Delivery Formulation as of 2022)
Table 33. Date of Key Manufacturers Enter into Injectable Drug Delivery Formulation Market
Table 34. Key Manufacturers Injectable Drug Delivery Formulation Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Injectable Drug Delivery Formulation Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Injectable Drug Delivery Formulation Sales by Region (2018-2024) & (K Pcs)
Table 38. Global Injectable Drug Delivery Formulation Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Injectable Drug Delivery Formulation Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Injectable Drug Delivery Formulation Sales Market Share in Value by Region (2018-2024)
Table 41. Global Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 42. Global Injectable Drug Delivery Formulation Sales by Region (2024-2034) & (K Pcs)
Table 43. Global Injectable Drug Delivery Formulation Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Injectable Drug Delivery Formulation Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Injectable Drug Delivery Formulation Sales Market Share in Value by Region (2024-2034)
Table 46. Global Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 47. Global Injectable Drug Delivery Formulation Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Injectable Drug Delivery Formulation Sales by Application (2018-2024) & (K Pcs)
Table 49. Global Injectable Drug Delivery Formulation Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Injectable Drug Delivery Formulation Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Injectable Drug Delivery Formulation Sales Market Share in Value by Application (2018-2024)
Table 52. Global Injectable Drug Delivery Formulation Price by Application (2018-2024) & (USD/Pcs)
Table 53. Global Injectable Drug Delivery Formulation Sales by Application (2024-2034) & (K Pcs)
Table 54. Global Injectable Drug Delivery Formulation Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Injectable Drug Delivery Formulation Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Injectable Drug Delivery Formulation Sales Market Share in Value by Application (2024-2034)
Table 57. Global Injectable Drug Delivery Formulation Price by Application (2024-2034) & (USD/Pcs)
Table 58. North America Injectable Drug Delivery Formulation Sales by Application (2018-2024) (K Pcs)
Table 59. North America Injectable Drug Delivery Formulation Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Injectable Drug Delivery Formulation Sales by Application (2018-2024) (K Pcs)
Table 61. Europe Injectable Drug Delivery Formulation Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Injectable Drug Delivery Formulation Sales by Application (2018-2024) (K Pcs)
Table 63. Asia-Pacific Injectable Drug Delivery Formulation Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Injectable Drug Delivery Formulation Sales by Application (2018-2024) (K Pcs)
Table 65. Latin America Injectable Drug Delivery Formulation Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Injectable Drug Delivery Formulation Sales by Application (2018-2024) (K Pcs)
Table 67. Middle East and Africa Injectable Drug Delivery Formulation Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Injectable Drug Delivery Formulation Sales by Country (2018-2024) & (K Pcs)
Table 69. North America Injectable Drug Delivery Formulation Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Injectable Drug Delivery Formulation Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Injectable Drug Delivery Formulation Sales Market Share in Value by Country (2018-2024)
Table 72. North America Injectable Drug Delivery Formulation Sales by Country (2024-2034) & (K Pcs)
Table 73. North America Injectable Drug Delivery Formulation Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Injectable Drug Delivery Formulation Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Injectable Drug Delivery Formulation Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Injectable Drug Delivery Formulation Sales by Country (2018-2024) & (K Pcs)
Table 77. Europe Injectable Drug Delivery Formulation Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Injectable Drug Delivery Formulation Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Injectable Drug Delivery Formulation Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Injectable Drug Delivery Formulation Sales by Country (2024-2034) & (K Pcs)
Table 81. Europe Injectable Drug Delivery Formulation Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Injectable Drug Delivery Formulation Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Injectable Drug Delivery Formulation Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Injectable Drug Delivery Formulation Sales by Region (2018-2024) & (K Pcs)
Table 85. Asia-Pacific Injectable Drug Delivery Formulation Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Injectable Drug Delivery Formulation Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Injectable Drug Delivery Formulation Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Injectable Drug Delivery Formulation Sales by Region (2024-2034) & (K Pcs)
Table 89. Asia-Pacific Injectable Drug Delivery Formulation Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Injectable Drug Delivery Formulation Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Injectable Drug Delivery Formulation Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Injectable Drug Delivery Formulation Sales by Country (2018-2024) & (K Pcs)
Table 93. Latin America Injectable Drug Delivery Formulation Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Injectable Drug Delivery Formulation Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Injectable Drug Delivery Formulation Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Injectable Drug Delivery Formulation Sales by Country (2024-2034) & (K Pcs)
Table 97. Latin America Injectable Drug Delivery Formulation Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Injectable Drug Delivery Formulation Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Injectable Drug Delivery Formulation Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Injectable Drug Delivery Formulation Sales by Country (2018-2024) & (K Pcs)
Table 101. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Injectable Drug Delivery Formulation Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Injectable Drug Delivery Formulation Sales by Country (2024-2034) & (K Pcs)
Table 105. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Injectable Drug Delivery Formulation Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share in Value by Country (2024-2034)
Table 108. Becton, Dickinson and Company (US) Company Information
Table 109. Becton, Dickinson and Company (US) Introduction and Business Overview
Table 110. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 111. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product
Table 112. Becton, Dickinson and Company (US) Recent Development
Table 113. Baxter International Inc. (US) Company Information
Table 114. Baxter International Inc. (US) Introduction and Business Overview
Table 115. Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 116. Baxter International Inc. (US) Injectable Drug Delivery Formulation Product
Table 117. Baxter International Inc. (US) Recent Development
Table 118. Gerresheimer AG (Germany) Company Information
Table 119. Gerresheimer AG (Germany) Introduction and Business Overview
Table 120. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 121. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Product
Table 122. Gerresheimer AG (Germany) Recent Development
Table 123. Pfizer, Inc. (US) Company Information
Table 124. Pfizer, Inc. (US) Introduction and Business Overview
Table 125. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 126. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Product
Table 127. Pfizer, Inc. (US) Recent Development
Table 128. Schott AG (Germany) Company Information
Table 129. Schott AG (Germany) Introduction and Business Overview
Table 130. Schott AG (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 131. Schott AG (Germany) Injectable Drug Delivery Formulation Product
Table 132. Schott AG (Germany) Recent Development
Table 133. Sandoz (Germany) Company Information
Table 134. Sandoz (Germany) Introduction and Business Overview
Table 135. Sandoz (Germany) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 136. Sandoz (Germany) Injectable Drug Delivery Formulation Product
Table 137. Sandoz (Germany) Recent Development
Table 138. Teva Pharmaceutical Industries Ltd. (Israel) Company Information
Table 139. Teva Pharmaceutical Industries Ltd. (Israel) Introduction and Business Overview
Table 140. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 141. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Product
Table 142. Teva Pharmaceutical Industries Ltd. (Israel) Recent Development
Table 143. Eli Lilly and Company (US) Company Information
Table 144. Eli Lilly and Company (US) Introduction and Business Overview
Table 145. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 146. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Product
Table 147. Eli Lilly and Company (US) Recent Development
Table 148. Key Raw Materials Lists
Table 149. Raw Materials Key Suppliers Lists
Table 150. Injectable Drug Delivery Formulation Market Trends
Table 151. Injectable Drug Delivery Formulation Market Drivers
Table 152. Injectable Drug Delivery Formulation Market Challenges
Table 153. Injectable Drug Delivery Formulation Market Restraints
Table 154. Injectable Drug Delivery Formulation Distributors List
Table 155. Injectable Drug Delivery Formulation Downstream Customers
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Injectable Drug Delivery Formulation Product Picture
Figure 2. Global Injectable Drug Delivery Formulation Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Injectable Drug Delivery Formulation Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Injectable Drug Delivery Formulation Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Conventional Drug Delivery Formulations
Figure 6. Global Conventional Drug Delivery Formulations Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Novel Drug Delivery Formulations
Figure 8. Global Novel Drug Delivery Formulations Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Long-acting Formulations
Figure 10. Global Long-acting Formulations Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Global Injectable Drug Delivery Formulation Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Injectable Drug Delivery Formulation Sales Market Share by Type in 2022 & 2034
Figure 13. North America Injectable Drug Delivery Formulation Sales Market Share in Volume by Type in 2022
Figure 14. North America Injectable Drug Delivery Formulation Sales Market Share in Value by Type in 2022
Figure 15. Europe Injectable Drug Delivery Formulation Sales Market Share in Volume by Type in 2022
Figure 16. Europe Injectable Drug Delivery Formulation Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Injectable Drug Delivery Formulation Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Injectable Drug Delivery Formulation Sales Market Share in Value by Type in 2022
Figure 19. Latin America Injectable Drug Delivery Formulation Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Injectable Drug Delivery Formulation Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Injectable Drug Delivery Formulation Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Injectable Drug Delivery Formulation Revenue in 2022
Figure 25. Injectable Drug Delivery Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Autoimmune Diseases
Figure 27. Global Autoimmune Diseases Sales YoY Growth (2018-2034) & (K Pcs)
Figure 28. Product Picture of Hormonal Disorders
Figure 29. Global Hormonal Disorders Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Product Picture of Oncology
Figure 31. Global Oncology Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Orphan Diseases
Figure 33. Global Orphan Diseases Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Global Injectable Drug Delivery Formulation Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Injectable Drug Delivery Formulation Sales Market Share by Application in 2022 & 2034
Figure 38. North America Injectable Drug Delivery Formulation Sales Market Share in Volume by Application in 2022
Figure 39. North America Injectable Drug Delivery Formulation Sales Market Share in Value by Application in 2022
Figure 40. Europe Injectable Drug Delivery Formulation Sales Market Share in Volume by Application in 2022
Figure 41. Europe Injectable Drug Delivery Formulation Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Injectable Drug Delivery Formulation Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Injectable Drug Delivery Formulation Sales Market Share in Value by Application in 2022
Figure 44. Latin America Injectable Drug Delivery Formulation Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Injectable Drug Delivery Formulation Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Injectable Drug Delivery Formulation Manufacturing Cost Structure
Figure 49. Injectable Drug Delivery Formulation Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries